GlobeNewswire

SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update
05/11/2026
Completed Phase 1 study of SCY-770, a first-in-class, highly selective, oral direct AMPK activator for the treatment of ADPKD; Phase 2 proof-of-concept trial to initiate in Q4 2026 Awarded BARDA contract providing up to [...]
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, to Participate in Upcoming November Investor Conferences
05/11/2026
SOUTH SAN FRANCISCO, Calif. and LIBERTY CORNER, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Marea Therapeutics, Inc. (“Marea”), a subsidiary of Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage [...]
Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics
05/11/2026
Care Bears by IM8 to launch, with great-tasting, science-backed gummy multivitamins for kids and adults in 1H 2027 Enters a global gummy supplements market projected to nearly double to ~US$47.8 billion by 2030 IM8 to [...]
Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion
05/11/2026
HINGHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, today announced that the Canadian Intellectual [...]
Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results
05/11/2026
– Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome; Primary and Key Secondary Endpoints Achieved Statistical Significance Versus Pre-Specified Alpha-Adjusted Target –Announces [...]
Disc Medicine Reports Third Quarter 2026 Financial Results and Provides Business Update
05/11/2026
Pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic protoporphyria (EPP) successfully met all primary and secondary endpoints Bitopertin NDA resubmission planned by end of 2026, with an FDA decision for [...]
Dogwood Therapeutics Announces Third Quarter 2026 Financial Results
05/11/2026
- Completed the Halneuron ® Phase 2b trial in Chemotherapy Induced Neuropathy, top-line results to be announced in November 2026 - - Phase 2b Long-Term Extension Study fully recruited, 95 patients enrolled, assessing [...]
Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
05/11/2026
Company to host conference call to discuss financial results and provide a corporate update on November 12, 2026 at 4:30 p.m. ET SCOTTSDALE, Ariz., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey [...]
Sparrow Pharmaceuticals Announces Expansion Cohorts in Phase 2b CAPTAIN-T2D Trial to Evaluate Clofutriben Across the Full Range of Cortisol Levels in Difficult-to-Control Type 2 Diabetes
05/11/2026
CAPTAIN-T2D remains on track, with topline data from the original and expansion cohorts expected by end-of-year (EOY) 2027 to enable pivotal Phase 3 readiness BOSTON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sparrow [...]
REMINDER TO VOTE: 20/20 BioLabs Special Meeting of Stockholders to Be Held December 9, 2026
05/11/2026
Board of Directors Recommends a Vote FOR Each Proposal, Including a Reverse Stock Split Authorization Intended to Provide Flexibility to Regain Compliance with Nasdaq’s $1.00 Minimum Bid Price Requirement Stockholders [...]
HCW Biologics Secures up to $10.0 Million in Cash Through Debt Financing
05/11/2026
Provides funding needed to complete HCW9302 Phase 1 study in alopecia areata and establish Recommended Phase 2 Dose MIRAMAR, Fla., Nov. 05, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics [...]
John Patrick University and Advanced Imaging Review Launch “Grow Your Own” Program to Build Healthcare Imaging Talent
05/11/2026
New initiative addresses radiology shortage and helps hospitals and health systems develop existing employees into radiologic technologists and advanced imaging professionals while they continue working SOUTH BEND, Ind [...]
Octo Health Launches Beta to Make Proactive, Personalized Healthcare More Accessible
05/11/2026
Octo Health brings medical records, lab results, medications and health data into one health timeline, giving consumers a more complete picture of their health By combining annual testing of more than 100 biomarkers [...]
Precision Optics Announces $2 Million Follow-On Order from Existing Top-Tier Aerospace Customer
05/11/2026
Order received ahead of expectations driving further conviction in forecasted fiscal 2027 results LITTLETON, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a [...]
INVO Fertility Partners with PatientFi to Help Make Fertility Treatment More Affordable
05/11/2026
Flexible financing options help patients manage treatment costs as INVO continues to expand its fertility services SARASOTA, Fla., Nov. 05, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “ [...]
Koç Healthcare Marks European Fertility Week 2026 with a Call for More Supportive Workplaces
05/11/2026
Under this year’s “Double Duty” theme, two doctors highlight the often unseen demands of fertility treatment alongside professional and family responsibilities ISTANBUL, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Koç Healthcare [...]
Sanuwave Health Comments on 2027 Medicare Physician Fee Schedule Rate for Ultramist
05/11/2026
CMS establishes $314.54 reimbursement rate for CPT code 97610 for 2027, an approximately 21% reduction vs 2026 rate of $397.81 2027 Hospital outpatient rate for 97610 code set at $235.04, an approximately 15% increase [...]
AIM ImmunoTech Highlights Ampligen® Opportunity to Potentially Extend Benefits of RAS-Targeted Therapies in Pancreatic Cancer
05/11/2026
New investor presentation outlines scientific rationale for combining Ampligen’s immune-stimulating activity with daraxonrasib’s targeted RAS inhibition to potentially prolong clinical benefit Previously reported [...]
Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry
05/11/2026
The 6-month target lesion primary patency (TLPP) 1 and access circuit primary patency (ACPP) 2 for patients in the arteriovenous fistula (AVF) cohort were 92.7% and 76.7%, respectively The real-world patency results [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum